Academic Publication Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
Correlated Market Trend: Access Management
Bridging academia to market: The 60-day public search velocity mapping directly to the core technology of this paper. Dashed line represents 7-day moving average.
AI Semantic Synergy Context
Connecting this academic literature to real-world market discussions and products.
Liquid biopsy in cancer: current status, challenges and future prospects
AbstractCancer has a high mortality rate across the globe, and tissue biopsy remains the gold standard for tumor diagnosis due to its high level of laboratory standardization, good consistency of r...
Liquid biopsy in cancer management: Integrating diagnostics and clinical applications
No description provided.
Liquid Biopsy Based on Cell-Free DNA and RNA
This review delves into the rapidly evolving landscape of liquid biopsy technologies based on cell-free DNA (cfDNA) and cell-free RNA (cfRNA) and their increasingly prominent role in precision medi...
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
No description provided.
SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives
AbstractLiquid biopsy has emerged as a promising non-invasive strategy for cancer diagnosis, enabling the detection of various circulating biomarkers, including circulating tumor cells (CTCs), circ...
Frequently Asked Questions (FAQ)
Curated market intelligence mapped to this research.
What is the core focus of the research titled 'Liquid biopsy in cancer management: Integrating diagnostics and clinical applications'?
This literature focuses on:
Which startups are commercializing the technology behind Liquid biopsy in cancer management: Integrating diagnostics and clinical applications?
Products like Fluido are bringing this to market. Their focus is: Turn any Figma shape into liquid metal in one click.
What other academic literature is closely related to 'Liquid biopsy in cancer management: Integrating diagnostics and clinical applications'?
Yes, highly correlated activity was mapped. An entry titled 'Liquid biopsy in cancer: current status, challenges and future prospects' discusses this: AbstractCancer has a high mortality rate across the globe, and tissue biopsy remains the gold standard for tumor diagnosis due to its high level of...
Cite this Market Intelligence Report
Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.
Commercial Realization
Startups and Open Source tools heavily associated with the concepts explored in this paper.
-
Product HuntFluido
SaaS Metrics